Home Applications 202811 Application 202811
Type NDA
Sponsor ALLERGAN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LINZESS LINACLOTIDE CAPSULE;ORAL 145MCG Yes Yes 002 LINZESS LINACLOTIDE CAPSULE;ORAL 290MCG Yes No 003 LINZESS LINACLOTIDE CAPSULE;ORAL 72MCG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202811-001 LINZESS LINACLOTIDE 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 N202811-002 LINZESS LINACLOTIDE 290MCG CAPSULE / ORAL RLD 2012-08-30 N202811-003 LINZESS LINACLOTIDE 72MCG CAPSULE / ORAL RLD, RS 2017-01-25
Orange Book patents# Current patent rows page 1 of 1 · 42 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N202811-001 7304036 2026-08-30 U-1278 Drug substance, Drug product 2012-09-18 N202811-001 7304036 2026-08-30 U-1516 Drug substance, Drug product 2012-09-18 N202811-001 7304036 2026-08-30 U-4345 Drug substance, Drug product 2012-09-18 N202811-001 7304036*PED 2027-02-28 Pediatric extension N202811-001 8933030 2031-02-17 U-4345 Drug product 2015-02-06 N202811-001 8933030*PED 2031-08-17 Pediatric extension N202811-001 8748573 2031-10-30 U-1515 2014-06-11 N202811-001 8748573 2031-10-30 U-1516 2014-06-11 N202811-001 8748573 2031-10-30 U-4345 2014-06-11 N202811-001 8802628 2031-10-30 Drug product 2014-08-19 N202811-001 8748573*PED 2032-04-30 Pediatric extension N202811-001 8802628*PED 2032-04-30 Pediatric extension N202811-001 9708371 2033-08-16 U-1515 Drug product 2017-08-10 N202811-001 9708371 2033-08-16 U-1516 Drug product 2017-08-10 N202811-001 9708371 2033-08-16 U-4345 Drug product 2017-08-10 N202811-001 9708371*PED 2034-02-16 Pediatric extension N202811-002 7304036 2026-08-30 U-1278 Drug substance, Drug product N202811-002 7304036 2026-08-30 U-1516 Drug substance, Drug product N202811-002 7304036*PED 2027-02-28 Pediatric extension N202811-002 8933030 2031-02-17 Drug product 2015-02-06 N202811-002 8933030*PED 2031-08-17 Pediatric extension N202811-002 8748573 2031-10-30 U-1515 2014-06-11 N202811-002 8748573 2031-10-30 U-1516 2014-06-11 N202811-002 8802628 2031-10-30 Drug product 2014-08-19 N202811-002 8748573*PED 2032-04-30 Pediatric extension N202811-002 8802628*PED 2032-04-30 Pediatric extension N202811-002 9708371 2033-08-16 U-1515 Drug product 2017-08-10 N202811-002 9708371*PED 2034-02-16 Pediatric extension N202811-003 7304036 2026-08-30 U-1516 Drug substance, Drug product 2017-02-24 N202811-003 7304036 2026-08-30 U-3644 Drug substance, Drug product 2017-02-24 N202811-003 7304036*PED 2027-02-28 Pediatric extension N202811-003 8933030 2031-02-17 U-1516 Drug product 2017-02-24 N202811-003 8933030 2031-02-17 U-3644 Drug product 2017-02-24 N202811-003 10675325 2031-08-11 Drug product 2020-06-22 N202811-003 10702576 2031-08-11 U-1516 2020-08-04 N202811-003 10702576 2031-08-11 U-3644 2020-08-04 N202811-003 8933030*PED 2031-08-17 Pediatric extension N202811-003 10675325*PED 2032-02-11 Pediatric extension N202811-003 10702576*PED 2032-02-11 Pediatric extension N202811-003 9708371 2033-08-16 U-1516 Drug product 2017-08-10 N202811-003 9708371 2033-08-16 U-3644 Drug product 2017-08-10 N202811-003 9708371*PED 2034-02-16 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202811-002 LINZESS 290MCG CAPSULE / ORAL RLD 2012-08-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N202811-003 LINZESS 72MCG CAPSULE / ORAL RLD, RS 2017-01-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N202811-001 LINZESS 145MCG CAPSULE / ORAL RLD, RS 2012-08-30 8072bd15b7f6…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2021-03-12 10:30 UTC 2021-03 N202811-001 AB 1 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N202811-002 AB 1 5aa47cf7b7d7…
Observed Orange Book patent history# Patent history page 1 of 38 · 1,490 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N202811-001 7304036 2026-08-30 U-1278 Drug substance, Drug product 2012-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 7304036 2026-08-30 U-4345 Drug substance, Drug product 2012-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 7304036 2026-08-30 U-1516 Drug substance, Drug product 2012-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 7304036*PED 2027-02-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8933030 2031-02-17 U-4345 Drug product 2015-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8933030*PED 2031-08-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8748573 2031-10-30 U-1515 2014-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8748573 2031-10-30 U-1516 2014-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8748573 2031-10-30 U-4345 2014-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8802628 2031-10-30 Drug product 2014-08-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8748573*PED 2032-04-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 8802628*PED 2032-04-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 9708371 2033-08-16 U-1515 Drug product 2017-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 9708371 2033-08-16 U-1516 Drug product 2017-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 9708371 2033-08-16 U-4345 Drug product 2017-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-001 9708371*PED 2034-02-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 7304036 2026-08-30 U-1278 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 7304036 2026-08-30 U-1516 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 7304036*PED 2027-02-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8933030 2031-02-17 Drug product 2015-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8933030*PED 2031-08-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8748573 2031-10-30 U-1516 2014-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8748573 2031-10-30 U-1515 2014-06-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8802628 2031-10-30 Drug product 2014-08-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8748573*PED 2032-04-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 8802628*PED 2032-04-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 9708371 2033-08-16 U-1515 Drug product 2017-08-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-002 9708371*PED 2034-02-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 7304036 2026-08-30 U-1516 Drug substance, Drug product 2017-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 7304036 2026-08-30 U-3644 Drug substance, Drug product 2017-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 7304036*PED 2027-02-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 8933030 2031-02-17 U-1516 Drug product 2017-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 8933030 2031-02-17 U-3644 Drug product 2017-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 10675325 2031-08-11 Drug product 2020-06-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 10702576 2031-08-11 U-1516 2020-08-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 10702576 2031-08-11 U-3644 2020-08-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 8933030*PED 2031-08-17 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 10675325*PED 2032-02-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 10702576*PED 2032-02-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202811-003 9708371 2033-08-16 U-1516 Drug product 2017-08-10 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 51 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 18 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1201 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1202 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current 0456-1203 Linzess linaclotide Allergan, Inc. NDA Current